Biomolecular interaction kinetics underpin essential cellular mechanisms, yet quantitative databases remain scarce for RNA-protein interactions (RPIs)-a critical regulatory axis in post-transcriptional control, synthetic biology, and therapeutic development. We previously established KDBI (Kinetic Data of Bio-molecular Interactions database) to catalog quantitative kinetics data across diverse biomolecular interaction types. Here, we present KDBI-RP, a dedicated extension focused on RPI kinetics, addressing the growing demand for RNA-centric kinetic research. KDBI-RP systematically integrates binding data for RNA-protein interactions, including kinetic rate constants-association (kon, 3657 entries) and dissociation (koff, 3761 entries)-supplemented by equilibrium dissociation constants (Kd, 175,932 entries). The database offers well-curated information on kinetic constants, assay conditions, literature sources, and comprehensive sequence, structural, and functional annotations for proteins, RNAs, and their complexes. KDBI-RP is freely accessible at http://www.kdbirp.aiddlab.com. We anticipate that KDBI-RP will serve as a valuable resource for the RNA biology and RNA-based medicine research communities.
Ureaplasma is one of the smallest pathogenic bacteria, generating approximately 95% of its adenosine triphosphate (ATP) solely through urease. Studies on Ureaplasma parvum, a species of Ureaplasma, have confirmed that adding urease inhibitors inhibits bacterial growth. The Km and Vmax of the urease-mediated reaction were estimated to be 4.3 ± 0.2 mM and 3,333.3 ± 38.0 μmol NH3/min/mg protein, respectively. The cryo-electron microscopy (cryo-EM) structure of Ureaplasma parvum urease (UPU) at a resolution of 2.03 Å reveals a trimer of heterotrimers comprising three proteins: UreA, UreB, and UreC. The active site is well conserved among the known ureases. However, the Vmax of UPU was higher than that of most known ureases, including those ureases derived from Sporosarcina pasteurii (SPU) and Klebsiella aerogenes (KAU) with identical oligomeric state. All-atom molecular dynamics simulations showed that the flap and UreB are more open in UPU than SPU and KAU. His-tagged wild-type recombinant UPU (WT-rUPU) revealed estimated Km and Vmax values of 4.1 ± 0.3 mM and 769.2 ± 7.4 µmol NH3/min/mg protein, respectively. Amino acid substitutions of recombinant UPUs within the flap region to SPU. Amongst the flap region variants, the Vmax of K331N variant was 48-fold lower than that of WT-rUPU. ICP-MS analysis reveals that one molecule of UPU, WT-rUPU, and K331N-rUPU contains 3.7, 0.8, and 0.1 Ni2+ atoms, respectively, suggesting that a wide-open flap of urease may contribute to delivering nickel into the enzyme, resulting in a high Vmax. Ureaplasma evolved highly efficient UPU through a few amino acid substitutions in the disorganized loop of the mobile flap region.
Coronaviruses, including SARS-CoV-2, pose a significant threat to global health. A critical step in viral maturation involves the proteolytic processing of viral polyproteins into functional nonstructural proteins (NSPs), with NSP4 being specifically cleaved by the main protease, NSP5, to release mature components. Through an integrative approach combining X-ray crystallography, NMR spectroscopy, and molecular dynamics simulations, we reveal that the C-terminal domain of NSP4 (NSP4-CTD) undergoes dynamic interconversion among multiple conformational states on distinct timescales. These states are characterized by variations in the position and secondary structure of the NSP4-CTD's C-terminal tail region, encompassing an undocked conformation, a docked extended conformation, and a docked helical conformation. We demonstrate that the formation of this C-terminal helix is influenced by both local sequence and overall structural context, playing a crucial role in positioning NSP4 relative to NSP5 and, consequently, modulating the efficiency of the autoprocessing event. While current antiviral therapeutic development has predominantly focused on targeting the mature NSP5 protease, our findings highlight the dynamic NSP4 C-terminal tail as a novel and promising target for antiviral intervention.

